NCT06222593
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06222593
Title Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination with Sunitinib in Patients with TKIs-resistant RCC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors State University of New York at Buffalo
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.